Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19/BCMA CAR T-cells”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Testing effectiveness (Phase 2)UnknownNCT04714593
What this trial is testing

Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia， B-Cell
Shanxi Province Cancer Hospital 24
Very early researchTemporarily pausedNCT07604792
What this trial is testing

FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.

Who this might be right for
Autoimmune Diseases
Beijing Boren Hospital 9
Early research (Phase 1)Looking for participantsNCT07715136
What this trial is testing

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

Who this might be right for
Inflammatory Myopathy
iCell Gene Therapeutics 10
Very early researchUnknownNCT05263817
What this trial is testing

A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis

Who this might be right for
POEMS SyndromeAmyloidosisAutoimmune Hemolytic Anemia+1 more
Zhejiang University 75
Early research (Phase 1)Looking for participantsNCT07073547
What this trial is testing

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

Who this might be right for
Multiple Myeloma
AstraZeneca 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05459870
What this trial is testing

CAR-T Cells Targeting Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute 30
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Not applicableLooking for participantsNCT07359014
What this trial is testing

Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapse Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Not applicableLooking for participantsNCT07558850
What this trial is testing

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisDermatomyositisSystemic Lupus Erythematosus+1 more
The First Affiliated Hospital with Nanjing Medical University 72
Very early researchLooking for participantsNCT07241468
What this trial is testing

An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease

Who this might be right for
Relapsed/Refractory Immune NephropathyRelapsed/Refractory Immune-mediated Kidney Disease
Changhai Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT07328581
What this trial is testing

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
iCell Gene Therapeutics 20
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04846439
What this trial is testing

Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

Who this might be right for
Platelet Transfusion RefractorinessAcute Leukemia in Remission
The First Affiliated Hospital of Soochow University 20
Very early researchNot Yet RecruitingNCT06986434
What this trial is testing

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Who this might be right for
Relapsed or Refractory Plasma Cell NeoplasmsLymphomas/Leukemias With Plasmacytic Differentiation
Affiliated Hospital to Academy of Military Medical Sciences 20
Very early researchNot Yet RecruitingNCT07077330
What this trial is testing

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Who this might be right for
Relapsed or Refractory Plasma Cell Neoplasms
Chinese PLA General Hospital 20
Very early researchLooking for participantsNCT06920433
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Zhejiang University 18
Very early researchUnknownNCT04236011
What this trial is testing

BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 15
Not applicableLooking for participantsNCT07052565
What this trial is testing

CAR-T Cells Therapy for Patients With Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Anhui Provincial Hospital 18
Next Page